Note 1: Caspofungin results in decreased activity of HNMT protein
Select any link to see items in a related category.
more general categories information about this item 2. Interaction: Human Genes and Chemicals 2. Interaction: Human Genes and Chemicals Decreases (5154) activity (2549) C01. Bacterial Infections and Mycoses C01. Bacterial Infections and Mycoses Infection [MESH:D007239] (4109) Sepsis [MESH:D018805] (3556) Fungemia [MESH:D016469] (6) Candidemia [MESH:D058387] (5) Skin Diseases, Infectious [MESH:D012874] (415) Dermatomycoses [MESH:D003881] (267) Hyalohyphomycosis [MESH:D060605] (17) Aspergillosis [MESH:D001228] (13) Mycoses [MESH:D009181] (385) Candidiasis [MESH:D002177] (307) Candidiasis, Invasive [MESH:D058365] (8) Candidemia [MESH:D058387] (5) Dermatomycoses [MESH:D003881] (267) Hyalohyphomycosis [MESH:D060605] (17) Aspergillosis [MESH:D001228] (13) Fungemia [MESH:D016469] (6) Candidemia [MESH:D058387] (5) Hyalohyphomycosis [MESH:D060605] (20) Aspergillosis [MESH:D001228] (14) C08. Respiratory Tract Diseases C08. Respiratory Tract Diseases Respiratory Tract Diseases [MESH:D012140] (7881) Bronchial Diseases [MESH:D001982] (4382) Asthma [MESH:D001249] (4098) Lung Diseases [MESH:D008171] (7249) Lung Diseases, Fungal [MESH:D008172] (35) Pulmonary Aspergillosis [MESH:D055732] (10) Invasive Pulmonary Aspergillosis [MESH:D055744] (4) Lung Diseases, Obstructive [MESH:D008173] (4697) Asthma [MESH:D001249] (3903) Nose Diseases [MESH:D009668] (1504) Rhinitis [MESH:D012220] (1134) Respiratory Hypersensitivity [MESH:D012130] (4401) Asthma [MESH:D001249] (4098) Respiratory Tract Infections [MESH:D012141] (3926) Rhinitis [MESH:D012220] (766) C09. Otorhinolaryngologic Diseases C09. Otorhinolaryngologic Diseases Otorhinolaryngologic Diseases [MESH:D010038] (3827) Nose Diseases [MESH:D009668] (1504) Rhinitis [MESH:D012220] (1134) C14. Cardiovascular Diseases C14. Cardiovascular Diseases Cardiovascular Diseases [MESH:D002318] (10123) Heart Diseases [MESH:D006331] (8614) Endocarditis [MESH:D004696] (70) C15. Hemic and Lymphatic Diseases C15. Hemic and Lymphatic Diseases Hematologic Diseases [MESH:D006402] (6174) Leukocyte Disorders [MESH:D007960] (2662) Leukopenia [MESH:D007970] (1921) Agranulocytosis [MESH:D000380] (1675) Neutropenia [MESH:D009503] (1629) C17. Skin and Connective Tissue Diseases C17. Skin and Connective Tissue Diseases Skin Diseases [MESH:D012871] (8774) Skin Diseases, Infectious [MESH:D012874] (2684) Dermatomycoses [MESH:D003881] (267) Hyalohyphomycosis [MESH:D060605] (17) Aspergillosis [MESH:D001228] (13) Skin Diseases, Vascular [MESH:D017445] (3288) Urticaria [MESH:D014581] (2668) C20. Immune System Diseases C20. Immune System Diseases Immune System Diseases [MESH:D007154] (7674) Hypersensitivity [MESH:D006967] (5873) Drug Hypersensitivity [MESH:D004342] (4000) Hypersensitivity, Immediate [MESH:D006969] (4980) Urticaria [MESH:D014581] (2668) Respiratory Hypersensitivity [MESH:D012130] (4250) Asthma [MESH:D001249] (3914) C23. Pathological Conditions, Signs and Symptoms C23. Pathological Conditions, Signs and Symptoms Pathologic Processes [MESH:D010335] (9863) Inflammation [MESH:D007249] (5241) Systemic Inflammatory Response Syndrome [MESH:D018746] (3563) Sepsis [MESH:D018805] (3562) Fungemia [MESH:D016469] (6) Candidemia [MESH:D058387] (5) C25. Chemically-Induced Disorders C25. Chemically-Induced Disorders Drug-Related Side Effects and Adverse Reactions [MESH:D064420] (5839) Drug Hypersensitivity [MESH:D004342] (4001) D12. Amino Acids, Peptides, and Proteins D12. Amino Acids, Peptides, and Proteins Peptides [MESH:D010455] (20561) Peptides, Cyclic [MESH:D010456] (2207) Echinocandins [MESH:D054714] (16) D27. Chemical Actions and Uses D27. Chemical Actions and Uses Pharmacologic Actions [MESH:D020228] (2566) Therapeutic Uses [MESH:D045506] (1611) Anti-Infective Agents [MESH:D000890] (386) Antifungal Agents [MESH:D000935] (55)
